{
    "2020-03-20": [
        [
            {
                "time": "2018-01-02",
                "original_text": "US FDA issues complete response letter for empagliflozin 2.5 mg as adjunct to insulin for adults with type 1 diabetes",
                "features": {
                    "keywords": [
                        "FDA",
                        "response letter",
                        "empagliflozin",
                        "insulin",
                        "type 1 diabetes"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "S&P 500 Could Find Support Around 2300, Market Technicians Say",
                "features": {
                    "keywords": [
                        "S&P 500",
                        "support",
                        "market technicians"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Pharma Stock Roundup: SNY, RHHBY, PFE's Coronavirus Product Development & Other Updates",
                "features": {
                    "keywords": [
                        "Pharma",
                        "SNY",
                        "RHHBY",
                        "PFE",
                        "Coronavirus",
                        "Product Development"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Kathryn Beiser to join Lilly as Vice President, Global Communications",
                "features": {
                    "keywords": [
                        "Kathryn Beiser",
                        "Lilly",
                        "Vice President",
                        "Global Communications"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}